4-Hydroxy-triazolam
CAS : 65686-11-5
Ref. 3D-QCA68611
| 5mg | À demander | |
| 10mg | À demander | |
| 25mg | À demander | |
| 50mg | À demander | |
| 100mg | À demander |
Informations sur le produit
- 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepin-4-ol, 8-chloro-6-(2-chlorophenyl)-1-methyl-
4-Hydroxy-triazolam is an analog of triazolam that has shown promising anticancer activity. It has been found to induce apoptosis in cancer cells and inhibit the growth of tumors. This compound is excreted primarily in urine and has been studied extensively as a potential inhibitor of kinases and elastase, both of which are involved in cancer progression. 4-Hydroxy-triazolam has also been investigated for its potential use as an anticancer drug in Chinese medicine. Although it shares some structural similarities with etomidate, a general anesthetic, it has distinct pharmacological properties that make it a promising candidate for further study as a cancer therapy.
Propriétés chimiques
Question d’ordre technique sur : 3D-QCA68611 4-Hydroxy-triazolam
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
